Skip to main content

5 insightful analyst questions from Calumet’s Q3 2026 earnings call

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CLMT Cover Image

Calumet delivered above-consensus top- and bottom-line results in the third quarter, but the market reacted negatively, reflecting investor concerns about margin compression and sustainability of recent outperformance. Management attributed quarterly gains to both its specialty products and renewables segments operating at full capacity amid tight supply conditions. CEO Todd Borgmann emphasized that plant reliability investments and an integrated specialty system helped Calumet capitalize on global supply chain disruptions, while also noting that the commercial team prioritized long-term customer relationships over chasing spot market margins. Borgmann cautioned that the current operating environment is elevated and not indicative of a new normal, stating, “What we will not point to this quarter is a new long-term norm.”

Is now the time to buy CLMT? Find out in our full research report (it’s free for active Edge members).

Calumet (CLMT) Q3 2026 highlights:

  • Revenue $1.68 billion vs S&P analyst consensus of $1.34 billion (56.1% year-on-year growth, 25.3% beat)
  • Adjusted EPS $2.79 vs S&P analyst consensus of $1.80 (55.1% beat)
  • Adjusted EBITDA $347.2 million vs analyst estimates of $264 million (20.6% margin, 31.5% beat)
  • Operating margin 27%, down from 30% in the same quarter last year
  • Market capitalization $3.49 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from Calumet’s Q3 earnings call

  • Conor Fitzpatrick (Bank of America) asked about the impact of U.S. political changes on SAF demand and policy. EVP Bruce Fleming said bipartisan support remains strong for renewable fuels and agricultural policy, and he expects SAF initiatives to continue regardless of political shifts.

  • Amit Dayal (H.C. Wainwright) questioned specialty segment margin strength in the current quarter. President Scott Obermeier said demand remains solid despite seasonal trends and expects increased production post-turnaround at Shreveport to meet market needs.

  • Josiah Knight (Goldman Sachs) asked about the impact of the CMR asset tie-in on SAF volumes and overall throughput. CEO Todd Borgmann explained the tie-in will allow immediate throughput increases and improved naphtha yields, supporting higher SAF production capacity.

  • Jason Gabelman (TD Cowen) requested clarification on near-term throughput and maintenance impacts. Borgmann said both Shreveport and Montana Renewables had about a month of maintenance, but both assets are now fully operational and expected to ramp production in the remainder of the year.

  • Gregg Brody (Bank of America) inquired about the sustainability of elevated specialty margins and long-term mid-cycle expectations. Borgmann stated margins are likely to remain elevated for some time due to supply constraints, but acknowledged a gradual normalization is expected as global capacity returns.

Catalysts in upcoming quarters

In the upcoming quarters, StockStory analysts will be watching (1) progress on the Montana Renewables MaxSAF expansion and its ability to ramp SAF production, (2) the pace of global supply chain normalization in specialty products and whether pricing power is sustained, and (3) further balance sheet deleveraging through debt repayments. Execution on operational reliability improvements and margin trends in Performance Brands will also be key markers to track.

Calumet currently trades at $40.67, down from $43.35 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

Our favorite stocks right now

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.90
+8.60 (3.32%)
AAPL  349.41
+7.04 (2.06%)
AMD  506.00
+56.96 (12.69%)
BAC  50.80
+1.38 (2.80%)
GOOG  287.89
+3.96 (1.40%)
META  642.42
+32.27 (5.29%)
MSFT  543.51
+12.90 (2.43%)
NVDA  176.40
-10.24 (-5.49%)
ORCL  118.82
+2.72 (2.34%)
TSLA  376.94
+18.72 (5.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.